Prossimo Advisors LLC decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 11.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,560 shares of the semiconductor company’s stock after selling 210 shares during the period. Prossimo Advisors LLC’s holdings in Synopsys were worth $800,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of SNPS. Independence Bank of Kentucky grew its position in shares of Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares in the last quarter. Saudi Central Bank bought a new stake in shares of Synopsys in the 1st quarter worth about $26,000. Princeton Global Asset Management LLC increased its holdings in shares of Synopsys by 481.8% in the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after acquiring an additional 53 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after buying an additional 53 shares during the period. Finally, AlphaQuest LLC increased its holdings in shares of Synopsys by 423.1% during the second quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock valued at $35,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. This trade represents a 19.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the sale, the chief executive officer owned 71,615 shares of the company’s stock, valued at $42,181,951.15. The trade was a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last three months. 0.62% of the stock is owned by insiders.
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter last year, the firm earned $3.43 earnings per share. The business’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. Morgan Stanley dropped their price objective on Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research note on Thursday, September 11th. Baird R W lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th. Rosenblatt Securities reaffirmed a “neutral” rating and set a $605.00 target price (down previously from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. The Goldman Sachs Group cut their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Finally, Mizuho cut their price target on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and an average target price of $556.33.
Get Our Latest Analysis on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- How to start investing in penny stocks
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
